From: Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
HDAC isoenzym
Percentage of patients with low expression
Percentage of patients with intermediate expression
Percentage of patients with high expression
HDAC 1
34.1
33.2
32.7
HDAC 2
43.4
32.5
24.1
HDAC 3
35.7
32.6
31.7